Company: IMCR
Filing Date: 2025-03-17
Form Type: 424B7
Source: 0001140361-25-008917
Chunk: 61

Company: Immunocore Holdings plc
Filing Date: 2025-03-17
Form: 424B7
Chunk 61
---
 including, the trading day immediately preceding the date of announcement of the distribution of such rights, options or warrants divided by(b) the number of ordinary shares then represented by one ADS. Any increase made under this clause (2) will be made successively whenever any such rights, options or warrants are distributed and shall become effective immediately after the open of business on the ex-dividend date for such distribution. To the extent that ordinary shares or the ADSs are not delivered after the expiration of such rights, options or warrants, the conversion rate shall be decreased to the conversion rate that would then be in effect had the increase with respect to the distribution of such rights, options or warrants been made on the basis of delivery of only the number of ordinary shares actually delivered (directly or in the form of ADSs). If such rights, options or warrants are not so distributed, the conversion rate shall be decreased to the conversion rate that would then be in effect if such ex-dividend date for such distribution had not occurred. For the purpose of this clause (2), in determining whether any rights, options or warrants entitle the holders to subscribe for or purchase ordinary shares (directly or in the form of ADSs) at a price per ordinary share that is less than such average of the last reported sale prices of the ordinary shares or the ADSs, as the case may be ( divided by, in the case of the ADSs, the number of ordinary shares represented by one ADS), for the 10 consecutive trading day period ending on, and including, the trading day immediately preceding the date of announcement of such distribution, and in determining the aggregate offering price of such ordinary shares or ADSs, there shall be taken into account any consideration received by us for such rights, options or warrants and any amount payable on exercise or conversion thereof, the value of such consideration, if other than cash, to be determined by us in good faith.

| (3) | If we distribute our shares, evidences of our indebtedness, other assets or property of ours or rights, options or warrants to acquire our shares or other securities, to all or substantially all holders of our ordinary shares (directly or in the form of ADSs), excluding: |

| • | dividends, distributions or issuances (including share splits) as to which an adjustment was effected pursuant to clause (1) or (2) above; |

| • | except as otherwise described below, rights issued pursuant to any shareholder rights plan of ours then in effect; |

| • | distributions of